Growth Metrics

Resmed (RMD) Capital Expenditures (2016 - 2025)

Resmed's Capital Expenditures history spans 17 years, with the latest figure at $28.5 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 38.24% year-over-year to $28.5 million; the TTM value through Dec 2025 reached $122.9 million, up 45.33%, while the annual FY2025 figure was $89.9 million, 9.65% down from the prior year.
  • Capital Expenditures reached $28.5 million in Q4 2025 per RMD's latest filing, down from $43.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $48.4 million in Q1 2022 to a low of $17.8 million in Q3 2024.
  • Average Capital Expenditures over 5 years is $28.5 million, with a median of $28.2 million recorded in 2021.
  • Peak YoY movement for Capital Expenditures: tumbled 40.6% in 2024, then surged 140.84% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $30.4 million in 2021, then dropped by 10.05% to $27.4 million in 2022, then fell by 14.61% to $23.4 million in 2023, then fell by 11.6% to $20.6 million in 2024, then skyrocketed by 38.24% to $28.5 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Capital Expenditures are $28.5 million (Q4 2025), $43.0 million (Q3 2025), and $30.6 million (Q2 2025).